Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

Sega Announced A Recommended Cash Offer Of EUR 9.25/Share To The Shareholders; EUR 1.48/Option To The Option Holders Of Rovio

By Charles Gross
April 17, 4:51 AM
Sega Europe Limited ("Sega Europe" or the "Offeror"), a private limited company incorporated and existing under the laws of England and Wales, that is directly and wholly owned by Sega Corporation ("Sega Corporation"), a corporation incorporated and existing under the laws of Japan, that, in turn, is directly and wholly owned by Sega Sammy Holdings Inc.

RVTTY

Read More
1 minute read

Amicus Therapeutics Granted Two U.S. Patents Tuesday: Highly Purified Batches Of Pharmaceutical Grade Migalastat And Methods Of Producing The Same; Methods Of Treating Fabry Patients Having Renal Impairment

By Charles Gross
April 11, 9:39 AM
Methods Of Treating Fabry Patients Having Renal Impairment Abstract: Provided are methods for treatment of Fabry disease in patients having HEK assay amenable mutations in α-galactosidase A. Certain methods comprise administering migalastat or a salt thereof every other day, such as administering about 150 mg of migalastat hydrochloride every other day.

FOLD

Read More
1 minute read

AstraZeneca, Swedish Orphan Biovitrum And Sanofi Have Updated And Simplified Their Contractual Arrangements Relating To The Development And Commercialization Of Nirsevimab In The US

By Charles Gross
April 11, 4:52 AM
AstraZeneca, Swedish Orphan Biovitrum AB (publ) (Sobi) and Sanofi have updated and simplified their contractual arrangements relating to the development and commercialisation of nirsevimab in the US. Given the upcoming launch of nirsevimab in the US and other markets, simplification of the prior arrangements clarifies the roles and responsibilities of relevant parties.   

AZN

Read More
4 minute read

Charlotte’s Web Formed Joint Venture With BAT And AJNA Biosciences To Seek FDA Approval For Proprietary Full Spectrum Hemp Extract Botanical Drug; Bat Acquired 20% Stake For $10M, With Charlotte’s Web And Ajna Each Owning 40% In JV

By Charles Gross
April 6, 10:52 AM
BAT acquires 20% stake for US$10 million, with Charlotte's Web and AJNA each owning 40% Renowned neurologist Dr. Orrin Devinsky, Chief Medical Advisor for AJNA, to lead the project

BTI